作者: Jeffrey J OLEARCZYK , Jeffrey E QUIGLEY , Bradford C MITCHELL , Tatsuo YAMAMOTO , In-Hae KIM
DOI:
关键词:
摘要: INTRODUCTION of nephropathy to ESRD (end-stage renal disease), which is the leading cause of mortality in patients with Type 2 Hypertension is a major risk factor for the development diabetes. It has been estimated that more than 3 million of nephropathy in patients with Type 2 diabetes [1]. If people in the United States have hypertension and left untreated, hypertension exacerbates the progression diabetes and that these disease states are co-morbid [1].